Q3 2025 DiaSorin SpA Earnings Call Transcript
Key Points
- Diasorin SpA (FRA:34D) achieved a 6% year-to-date growth in core businesses, excluding COVID impact and at constant exchange rates.
- The company successfully launched new assays, including a high throughput version of the Quantifiron assay for TB and a TSH receptor assay, enhancing their product portfolio.
- Diasorin SpA (FRA:34D) secured FDA approval for their 4-plex respiratory panel, which is expected to stabilize their MDX respiratory franchise.
- The company reported strong growth in the US market, with immuno diagnostics growing by 14% in Q3.
- Diasorin SpA (FRA:34D) is consolidating manufacturing in Europe, which is expected to streamline operations and reduce costs.
- The company faced a 30% decline in China due to the implementation of BBP2, impacting oncology product sales.
- Molecular diagnostics saw a 1% decline, with the MDX respiratory franchise suffering from increased competition and decreased volumes.
- The LTG segment experienced a 6% decline in Q3, attributed to seasonality and challenges in the life sciences market.
- Diasorin SpA (FRA:34D) anticipates a negative impact of approximately €11 million on profitability due to tariffs.
- The company is facing challenges in Europe, particularly in Germany and Italy, where testing volumes have decelerated due to healthcare reforms and seasonal trends.
Changes Do that to me.
Once is never in.
With a man like Do that to me.
I Getting of a man like.
Like Well.
Do that to want all.
As that by.
I want to.
For my heart to hear.
I hearing while I got to.
Like Well baby.
That to me once.
Ladies and gentlemen, please hold the line. The conference will begin shortly.
I want this never end up with a man.
I I can never A man like you.
Like Well maybe.
Good evening. This is the Corrusco conference operator. Welcome and thank you for joining the DAO 9 month 2025 years results conference call.
As a reminder, all participants are in listen-only mode.
After the presentation there will be an opportunity to ask questions.
Should anyone need assistance during the conference call, they may signal an operator by pressing N0 on their telephone.
At this time I would like to turn the conference over to Mr. Carloroa, CEO of Diasorin. Please go ahead, sir.
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
